EPO Patents = 5

Trademarks = 3

Forward Citations = 0

Loading Chart...

21 inventors (with patents filed for the assignee):

Moon Jong Noh (3 out of 3 patents)

Kwan Hee Lee (3 out of 3 patents)

Hyeon Youl Lee (2 out of 2 patents)

4. Sang Eun Noh (2 out of 2 patents)

5. Hyesun Lee (1 out of 37 patents)

6. Hyun W Bae (1 out of 68 patents)

7. Heonsik Choi (1 out of 5 patents)

8. Kyoungbaek Choi (1 out of 4 patents)

9. Sujeong Kim (1 out of 16 patents)

10. Hyeonyoul Lee (1 out of 4 patents)

11. Daewook Kim (1 out of 10 patents)

12. Kwangwook Ahn (1 out of 1 patent)

13. Youngsuk Yi (1 out of 4 patents)

14. Jun Ho Lee (1 out of 58 patents)

15. Heon Sik Choi (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12653842 - Treatment of intervertebral disc degeneration (2026-06-16),

2. 12629393 - Pharmaceutical composition for preventing or treating osteoarthritis (2026-05-19),

3. 11614441 - Method for assessing validity of cell therapy product (2023-03-28),

4. 11248211 - Primed cell therapy (2022-02-15),

5. 11191787 - Composition for treating inflammatory disease induced by hyperimmune response (2021-12-07),

6. 10584153 - Treatment of damaged nerve with PTEN inhibitor (2020-03-10),

Kolon Tissuegene, Inc. is a biotechnology company specializing in the development of advanced cell and gene therapies for various diseases. With a focus on tissue engineering and regenerative medicine, they are dedicated to creating innovative solutions to improve patient outcomes. Their cutting-edge research and development efforts make them a leader in the field of biotechnology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

6 Patents

#93 in Rockville, MD

#633 in Maryland

#44,949 in US

Rockville, MD, United States of America

Kolon Tissuegene, Inc.